Daniel Corey, MD, BA

Assistant Professor

Dr. Daniel Corey is a physician-scientist with advanced training in hematologic conditions. He practices at the Zuckerberg San Francisco General Hospital Hematology and Oncology clinic and the UCSF Parnassus outpatient clinics, where he also teaches medical students, residents, and fellows. Dr. Corey collaborates with colleagues across UCSF Health on projects involving advanced immune therapeutics to improve the clinical care and understanding of patients with hematologic disorders.

Education
- Internal Medicine Residency, Duke University Division of Internal Medicine
- Hematology Fellowship, Stanford University Division of Hematology & Oncology
MD, - Medicine, University of Washington School of Medicine
Publications

  1. Cieniewicz B, Oliveira E, Saxton M, Torabi D, Bhatta A, Kukutla P, Arballo A, Yang Z, Yu B, Fate M, Ning H, Corey L, Maiti A, Corey D. Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia. Volume 30 of Issue 9. Clinical cancer research : an official journal of the American Association for Cancer Research 2024. PMID: 38451195


  2. Brandon Cieniewicz, Ankit Bhatta, Damoun Torabi, Priya Baichoo, Mike Saxton, Alexander Arballo, Linh Nguyen, Sunil Thomas, Harini Kethar, Phanidhar Kukutla, Omolola Shoaga, Bi Yu, Zhuo Yang, Maria Fate, Edson Oliveira, Hongxiu Ning, Lawrence Corey, Daniel Corey. Molecular Therapy Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation 2023. PMID:


  3. Cieniewicz B, Bhatta A, Torabi D, Baichoo P, Saxton M, Arballo A, Nguyen L, Thomas S, Kethar H, Kukutla P, Shoaga O, Yu B, Yang Z, Fate M, Oliveira E, Ning H, Corey L, Corey D. Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation. Volume 31 of Issue 7. Molecular therapy : the journal of the American Society of Gene Therapy 2023. PMID: 37194236


  4. Corey D, Haeseleer F, Hou J, Corey L. Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells. Volume 28. Molecular therapy. Methods & clinical development 2022. PMID: 36514789


  5. Brandon Cieniewicz Ankit Bhatta Damoun Torabi Priya Baichoo Mike Saxton Alexander Arballo Linh Nguyen Sunil Thomas Harini Kethar Phanidhar Kukutla Omolola Shoaga Bi Yu Zhuo Yang Maria Fate Edson Oliveira Hongxiu Ning Lawrence Corey Daniel Corey. Journal for ImmunoTherapy of Cancer Chimeric engulfment receptor (CER) T cells with a TLR2 domain synergize with an EGFR inhibitor to target NSCLC cells in vitro and demonstrate APC-like function 2022. PMID:


  6. Daniel Corey, Sunil Thomas, Brandon Cieniewicz, Linh Nguyen, Jared Clever, Josephine Brysting, Remus Vezan, John Rossi, Kurt Diem, Lei Jin and Lawrence Corey. Journal for ImmunoTherapy of Cancer Enhanced antigen capture, antigen-presenting cell (APC)-like function, and cytotoxic responses with chimeric engulfment receptor (CER) T cells 2021. PMID:


  7. Tal MC, Torrez Dulgeroff LB, Myers L, Cham LB, Mayer-Barber KD, Bohrer AC, Castro E, Yiu YY, Lopez Angel C, Pham E, Carmody AB, Messer RJ, Gars E, Kortmann J, Markovic M, Hasenkrug M, Peterson KE, Winkler CW, Woods TA, Hansen P, Galloway S, Wagh D, Fram BJ, Nguyen T, Corey D, Kalluru RS, Banaei N, Rajadas J, Monack DM, Ahmed A, Sahoo D, Davis MM, Glenn JS, Adomati T, Lang KS, Weissman IL, Hasenkrug KJ. Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition. Volume 11 of Issue 3. mBio 2020. PMID: 32576678


  8. Rosental B, Kowarsky M, Seita J, Corey DM, Ishizuka KJ, Palmeri KJ, Chen SY, Sinha R, Okamoto J, Mantalas G, Manni L, Raveh T, Clarke DN, Tsai JM, Newman AM, Neff NF, Nolan GP, Quake SR, Weissman IL, Voskoboynik A. Complex mammalian-like haematopoietic system found in a colonial chordate. Volume 564 of Issue 7736. Nature 2018. PMID: 30518860


  9. Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, Ring AM, Connolly AJ, Weissman IL. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Volume 545 of Issue 7655. Nature 2017. PMID: 28514441


  10. Corey DM, Rosental B, Kowarsky M, Sinha R, Ishizuka KJ, Palmeri KJ, Quake SR, Voskoboynik A, Weissman IL. Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners. Volume 113 of Issue 23. Proceedings of the National Academy of Sciences of the United States of America 2016. PMID: 27217570


  11. Corey DM, Rinkevich Y, Weissman IL. Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte-Endothelial Recognition to Foster Tumor Immune Escape. Volume 76 of Issue 6. Cancer research 2015. PMID: 26719541


  12. Reinardy JL, Corey DM, Golzio C, Mueller SB, Katsanis N, Kontos CD. Phosphorylation of Threonine 794 on Tie1 by Rac1/PAK1 Reveals a Novel Angiogenesis Regulatory Pathway. Volume 10 of Issue 10. PloS one 2015. PMID: 26436659


  13. Voskoboynik A, Newman AM, Corey DM, Sahoo D, Pushkarev D, Neff NF, Passarelli B, Koh W, Ishizuka KJ, Palmeri KJ, Dimov IK, Keasar C, Fan HC, Mantalas GL, Sinha R, Penland L, Quake SR, Weissman IL. Identification of a colonial chordate histocompatibility gene. Volume 341 of Issue 6144. Science (New York, N.Y.) 2013. PMID: 23888037


  14. Voskoboynik A, Neff NF, Sahoo D, Newman AM, Pushkarev D, Koh W, Passarelli B, Fan HC, Mantalas GL, Palmeri KJ, Ishizuka KJ, Gissi C, Griggio F, Ben-Shlomo R, Corey DM, Penland L, White RA, Weissman IL, Quake SR. The genome sequence of the colonial chordate, Botryllus schlosseri. Volume 2. eLife 2013. PMID: 23840927


  15. Corey DM, Kim HW, Salazar R, Illescas R, Villena J, Gutierrez L, Sanchez J, Tabet SR. Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study. Volume 44 of Issue 4. Journal of acquired immune deficiency syndromes (1999) 2007. PMID: 17195766


  16. Corey D, Kim HW, Salazar R, Gutierrez L, Sanchez J, Tabet SR. The natural history of untreated HIV infection in Lima, Peru: implications for clinical trial endpoints for HIV vaccines. Volume 1 of Issue 4. Human vaccines 2005. PMID: 17012861